Monlunabant shows significant and clinically meaningful weight loss over 16 weeks in patients with obesity and metabolic syndrome, a phase 2a trial finds.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/novel-weight-loss-drug-shows-promise-obesity-treatment-2025a1000svl?src=rss
Author :
Publish date : 2025-10-23 13:17:00
Copyright for syndicated content belongs to the linked Source.
